Search clinical trials for: Clobetasol Propionate 0.05% Ointment

Total 185 results

Padagis LLC

Completed

Randomized Study to Compare the Bioavailability of Two Halobetasol Propionate 0.05% Topical Ointments

Healthy
Actavis Inc.

Completed

Pivotal Bioequivalence Study of Topically Delivered Halobetasol Propionate Ointment in Normal Skin in Healthy Adult Subjects

Healthy

United States
Oslo University Hospital
Photocure

Completed

Treatment of Female Genital Erosive Lichen Planus(GELP) With Hexaminolevulinate PDT

Genital Lichen Planus

Norway
Dermatology Consulting Services, PLLC

Completed

Anti-Inflammatory Effects of 0.045% Tazarotene/0.01% Halobetasol Lotion in Psoriasis

Psoriasis Vulgaris

United States
Padagis LLC

Completed

Randomized Study to Compare the Bioavailability of Three Halobetasol Propionate 0.05% Topical Creams

Healthy
Medstar Health Research Institute

Completed

Clobetasol Propionate Versus Fractionated Carbon Dioxide Laser for the Treatment of Lichen Sclerosus (CuRLS)

Vulvar Lichen Sclerosus

United States
Therapeutics, Inc.

Completed

Blinded Study of Topical Investigational Lotion Vs. Approved Cream in Treatment of Plaque Psoriasis

Plaque Psoriasis

United States
Garlapati Komali

Unknown

Topical Betamethasone and Clobetasol in Orabase in Oral Lichen Planus

Oral Lichen Planus

India
LEO Pharma

Completed

A Single-Centre Clinical Trial to Assess Steroid Induced Skin Atrophy on Healthy Skin

Skin and Connective Tissue Diseases

Germany
Icahn School of Medicine at Mount Sinai

Completed

Ammonium Lactate Lotion 12% (Lac-hydrin®) and Halobetasol Propionate Ointment 0.05% (Ultravate®) in the Treatment and Maintenance of Psoriasis

Plaque Psoriasis

United States
Pfizer

Completed

A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.

Plaque Psoriasis | Atopic Dermatitis

United States, Canada, United Kingdom, Japan
Galderma R&D

Completed

Efficacy, Tolerance and Satisfaction With CLOBEX® Spray When Used as Monotherapy or Add-on Therapy in Plaque Psoriasis

Psoriasis

United States
Patel, Rita Vikram, M.D.

Completed

Assessment for Tachyphylaxis to Topical Corticosteroids in the Treatment of Psoriasis (Tachyphylaxis)

Psoriasis
Medstar Health Research Institute
Patty Brisben Foundation For Women's Sexual Health; Society of Gynecologic...

Recruiting

Fractionated CO2 Laser With and Without Clobetasol for Treatment of Vulvar Lichen Sclerosus (VULVIE)

Vulvar Lichen Sclerosus

United States
Malmö University
Skane University Hospital

Recruiting

Efficacy of Topical Treatment With Clobetasol in Symptomatic Oral Lichen Planus.

Oral Lichen Planus

Sweden
LEO Pharma

Completed

A Psoriasis Plaque Test Comparing Products for the Treatment of Psoriasis Vulgaris

Psoriasis Vulgaris

France
Bayer

Terminated

BAY1003803 Single and Multiple Dose Escalation, Safety, Tolerability and Pharmacokinetics Study

Psoriasis

Germany
Mahidol University

Completed

Comparison of Efficacy of Intralesional Triamcinolone Injection and Clobetasol Propionate Ointment for Psoriatic Nails

Psoriatic Nails

Thailand
Bayer

Completed

1404003_OpenPsori.PlaqueTest to Eval.Eff.of Diff.Comp. to Mapracorat

Psoriasis

Germany
Padagis LLC

Completed

Randomized Study to Compare the Bioavailability of Two Clobetasol Propionate 0.05% Topical Foams

Healthy
Galderma R&D

Completed

A Comparison Between Clobetasol Propionate 0.05% (Clobex®) Spray and Clobetasol Propionate 0.05% (Olux®) Foam

Psoriasis

United States
Promius Pharma, LLC

Completed

DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis (HPA axis)

Psoriasis

United States
Galderma R&D

Completed

Efficacy/Safety/Subject Satisfaction/Duration of Response of Clobetasol Propionate Spray vs Ointment in Plaque Psoriasis

Plaque Psoriasis

United States
Galderma R&D

Completed

Efficacy, Safety, Preference and Response Duration of Clobex® Spray and Taclonex® Ointment in Psoriasis

Plaque Psoriasis

United States
LEO Pharma

Completed

A Clinical Trial to Assess the Potential of LEO 130852A Gel to Reduce Steroid Induced Skin Atrophy on Healthy Skin

Connective Tissue Diseases | Skin Tissue Diseases

Germany
Mahidol University

Completed

Topical Corticosteroids on the Incidence of Postinflammatory Hyperpigmentation After QsNdYAG Laser

Post Inflammatory Hyperpigmentation | Lentigines

Thailand
Galderma R&D

Completed

Evaluate Safety/Efficacy of Two Treatment Regimens for Vectical™ Ointment & Clobex® Spray for Moderate Plaque Psoriasis

Plaque Psoriasis

United States, Canada
Galderma R&D

Completed

Maintenance Effect of Clobex Shampoo on Participants With Moderate to Severe Scalp Psoriasis

Scalp Psoriasis

Canada
Salvat

Completed

Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-2) (CLOSE-2)

Cataract

United States
Salvat

Completed

Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-1) (CLOSE-1)

Cataract

United States
Hill Dermaceuticals, Inc.
Covance; Synteract, Inc.

Terminated

Clobetasol Topical Oil for Children With Moderate to Severe Atopic Dermatitis

Atopic Dermatitis

United States
Prof. Dr. Volker Viereck

Active, not recruiting

Clinical Trial to Demonstrate That the Dual Laser Therapy is Effective for the Treatment of Vulvar Lichen Sclerosus

Vulvar Lichen Sclerosus | Chronic Skin Disease

Switzerland
Taro Pharmaceuticals USA

Completed

A Study Comparing Halobetasol Propionate and Tazarotene Topical Lotion 0.01%/0.045% to Duobrii® Lotion (Halobetasol Propionate and Tazarotene Lotion), 0.01%/0.045% (Reference Listed Drug) in the Treatment of Moderate to Severe Plaque Psoriasis.

Plaque Psoriasis

United States
TWi Biotechnology, Inc.

Terminated

A Proof-of-Concept Study of Topical AC-203 in Patients With Bullous Pemphigoid

Bullous Pemphigoid

Taiwan
Therapeutics, Inc.

Completed

A Study to Determine the Efficacy and Safety of Halobetasol Propionate Lotion 0.05% in Subjects With Plaque Psoriasis

Psoriasis | Plaque Psoriasis

United States
Sun Pharmaceutical Industries Limited
Novum Pharmaceutical Research Services

Terminated

Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis

Atopic Dermatitis

United States
Skin Sciences, PLLC

Unknown

Efficacy and Safety of Sorilux in Maintenance Treatment of Moderate Type Plaque Psoriasis

Plaque Psoriasis

United States
Galderma R&D

Completed

Clobetasol Propionate Spray Versus Vehicle Spray for the Management of Moderate to Severe Plaque Psoriasis of the Scalp

Scalp Psoriasis

United States
Actavis Inc.

Completed

The Dose-response Study of Topically Delivered Halobetasol Propionate Ointment in Normal Skin in Healthy Adult Subjects

Healthy

United States
Icahn School of Medicine at Mount Sinai
Bausch Health Americas, Inc.

Completed

Combination of Halobetasol Propionate and Tazarotene Lotion (Duobrii®) for Palmoplantar Plaque Type Psoriasis

Plaque Psoriasis | Palmoplantar Psoriasis

United States
Actavis Inc.

Completed

Pivotal Bioequivalence Study of Topically Delivered Clobetasol Propionate Lotion in Healthy Adult Subjects

Healthy

United States
Icahn School of Medicine at Mount Sinai
Bausch Health Americas, Inc.

Recruiting

Duobrii Treatment of Acne Keloidalis Nuchae (AKN)

Acne Keloidalis Nuchae | AKN

United States
University of California, Davis

Withdrawn

Topical Clobetasol for the Treatment of Toxic Epidermal Necrolysis (TEN)

Toxic Epidermal Necrolysis

United States
The Hospital for Sick Children

Completed

A Trial of Clobetasol Propionate Versus Hydrocortisone in Children With Alopecia Areata

Alopecia Areata

Canada
First Hospital of China Medical University

Completed

A Trial That Compound Clobetasol Propionate Ointment Treats Patients With Mild to Moderate Psoriasis Vulgaris.

Psoriasis
Galderma R&D

Completed

Safety & Effectiveness of Clobex Spray, Followed by Calcitriol Ointment in Management of Plaque Psoriasis

Psoriasis

United States
Sun Pharmaceutical Industries Limited
Novum Pharmaceutical Research Services

Withdrawn

Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Plaque Psoriasis

Plaque Psoriasis
University Hospital Inselspital, Berne
University of Bern

Terminated

Progesterone vs Clobetasol Propionate in Vulvar Lichen Sclerosus

Vulvar Lichen Sclerosus

Switzerland
Callender Center for Clinical Research

Unknown

Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia

Alopecia

United States
Sun Pharmaceutical Industries Limited

Terminated

Evaluation of Adrenal Suppression Potential and Pharmacokinetics of Halobetasol Lotion 0.05%

Plaque Psoriasis

United States

3

Subscribe